Aerin Medical

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Aerin Medical sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 12 completed top decile by trial count

Aerin Medical: 14 sponsored US clinical trials, none currently recruiting.

Aerin Medical sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. The most-studied condition in this pipeline is Nasal Airway Obstruction, with 2 trials.

Top-decile sponsor footprint

Aerin Medical ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

14 total, page 1 of 1

ACTIVE NOT RECRUITING

A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.

NCT06922955
ACTIVE NOT RECRUITING NA

A Study of RhinAer Stylus for Treating Chronic Rhinitis

NCT06599736
COMPLETED

An Ambispective Registry Study Comparing Clinical Outcomes of Surgical Interventions for the Treatment of Nasal Airway Obstruction.

NCT06992037
COMPLETED NA

The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)

NCT05099263
COMPLETED

Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device

NCT04684875
COMPLETED NA

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

NCT04614324
COMPLETED NA

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

NCT04549545
COMPLETED NA

RhinAer Procedure for Treatment of Chronic Rhinitis Study

NCT04533438
COMPLETED NA

Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction

NCT04277507
COMPLETED NA

Posterior Nasal Nerve (PNN) Rhinitis Study

NCT03727347
COMPLETED

Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device

NCT03290300
COMPLETED NA

Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction

NCT03156270
COMPLETED NA

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

NCT02914236
COMPLETED NA

InFlux System for Nasal Breathing Improvement

NCT01960816

Therapeutic Areas

Nasal Airway Obstruction 2
Chronic Rhinitis 2
Nasal Obstruction 1

How the Aerin Medical archive is shaped

14 indexed studies, none listed as recruiting (0% open); 12 completed (86%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Nasal Airway Obstruction (2 trials), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Aerin Medical: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Aerin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Aerin Medical3-C Institute for Social DevelopmentAbbott Medical OpticsAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA10xBio22nd Century Group23andMe3 Waves Wellness
Aerin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Aerin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Aerin Medical page

14 registered trials is a research-attention snapshot, not an endorsement of Aerin Medical or any single study.

  • None of Aerin Medical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Nasal Airway Obstruction is the condition Aerin Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nasal Airway Obstruction trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Aerin Medical pipeline card: 14 registered trials from official public datasets.Report a data error.